Product Highlight - XOFLUZA
16 Sep 2020
ONE AND DONE
* Infectious virus
**In otherwise healthy patients with influenza in the CAPSTONE-1 study, Xofluza demonstrated a median time to cessation of viral shedding of 24 hours vs. 96 hours with placebo and 72 hours with oseltamivir (p<0.001 vs. both placebo and oseltamivir)
^Median time to alleviation of symptoms was 54 hours (2.3 days) with Xofluza compared with 80 hours (3.3 days) with placebo (p<0.001), in otherwise healthy patients with influenza in the CAPSTONE-1 study.